-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Hebei Province Fine Chemical Industry Association Conducts a Research Visit to Guangxiang Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group
Category:
TIME：2026-01-03
To accurately grasp the development trajectory of the fine chemicals industry in our province, gain a clear understanding of the current status and needs of leading enterprises in key sectors, and scientifically plan the association’s next steps, on December 28, 2025, Zhao Sitao, Executive President of the Hebei Provincial Fine Chemical Industry Association, led a research delegation to conduct a focused field study at enterprises such as Guangxiang Pharmaceutical Group.
At Guangxiang Pharmaceutical, the research team gained an in-depth understanding of the company’s business development and the implementation of its environmental protection and safety measures, with particular emphasis on the innovative advances the company has made in the pharmaceutical and chemical industries. During a symposium with Zhu Shujie, Chairman of Guangxiang Pharmaceutical, Zhao Sitao pointed out that fine chemicals are a critical enabler of high-quality manufacturing development and that it is essential to remain committed to innovation-driven growth and accelerate the move toward the mid- to high-end segments of the industrial and value chains.
According to reports, this research study aims to systematically identify the key challenges currently facing the industry, solicit input and recommendations from enterprises on policy support, technological innovation, and supply-chain collaboration, and gain insight into their future development plans. In doing so, it seeks to build consensus and provide decision-making support for promoting the industry’s healthy development, while helping enterprises achieve new breakthroughs in technological upgrading, supply-chain coordination, and green development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
